The Vanguard Group 13D and 13G filings for Bio-Rad Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-20 4:50 pm Purchase |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 1,907,640 8.370% |
1,716,876 (+900.00%) |
Filing |
| 2024-11-12 1:27 pm Unchanged |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 190,764 8.360% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:22 am Sale |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 190,764 8.360% |
-2,236,373 (-92.14%) |
Filing |
| 2024-03-11 09:59 am Purchase |
2024-02-29 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 2,427,137 10.360% |
37,248 (+1.56%) |
Filing |
| 2024-02-13 5:00 pm Sale |
2023-12-29 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 2,389,889 9.930% |
-1,547 (-0.06%) |
Filing |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 2,391,436 9.660% |
103,971 (+4.55%) |
Filing |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 2,287,465 9.210% |
15,092 (+0.66%) |
Filing |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 2,272,373 9.180% |
294,846 (+14.91%) |
Filing |